Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized Blood Glucose Control in ICU (CONTROLING)
NCT02244073Terminated
- Sponsor
- Hospices Civils de Lyon
- Start
- May 2015
- Primary completion
- Jan 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of human insulin in critical illness, sponsored by Hospices Civils de Lyon. Primary endpoint: All-cause mortality at 90 days. Started May 2015; status: terminated.
02
Drugs
human insulin
03
Conditions
critical illness
Beyond the preview
Go deeper on NCT02244073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02244073.